You are here

Article Text

Article menu
Download PDFPDF
Matters arising
Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
  1. J A Gómez-Puerta,
  2. R Sanmartí,
  3. J R Rodríguez-Cros,
  4. J D Cañete
  1. Arthritis Unit, Rheumatology Department, IDIBAPS, Hospital Clínic de Barcelona, Spain
  1. Correspondence to:
    Dr R Sanmartí
    Rheumatology Department, Hospital Clínic, Villarroel 170, Barcelona, Catalonia, Spain; sanmarticlinic.ub.es

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read the recent article by van Vollenhoven et al1 on the efficacy of one tumour necrosis factor α antagonist (infliximab or etanercept) when the other has failed with great interest. The authors concluded that infliximab is efficacious in a significant proportion of patients who have not responded to etanercept. No conclusive results were reported when they analysed the opposite situation, probably because 11 of the 13 patients who switched from …

    View Full Text